99 related articles for article (PubMed ID: 26149988)
1. Effective Sequestration of Clostridium difficile Protein Toxins by Calcium Aluminosilicate.
Sturino JM; Pokusaeva K; Carpenter R
Antimicrob Agents Chemother; 2015 Dec; 59(12):7178-83. PubMed ID: 26149988
[TBL] [Abstract][Full Text] [Related]
2. Nanobodies against C. difficile TcdA and TcdB reveal unexpected neutralizing epitopes and provide a toolkit for toxin quantitation in vivo.
Kordus SL; Kroh HK; Rodríguez RC; Shrem RA; Peritore-Galve FC; Shupe JA; Wadzinski BE; Lacy DB; Spiller BW
PLoS Pathog; 2023 Oct; 19(10):e1011496. PubMed ID: 37871122
[TBL] [Abstract][Full Text] [Related]
3. RstA Is a Major Regulator of Clostridioides difficile Toxin Production and Motility.
Edwards AN; Anjuwon-Foster BR; McBride SM
mBio; 2019 Mar; 10(2):. PubMed ID: 30862746
[No Abstract] [Full Text] [Related]
4. A Streamlined Method to Obtain Biologically Active TcdA and TcdB Toxins from
Sapa D; Brosse A; Coullon H; Péan de Ponfilly G; Candela T; Le Monnier A
Toxins (Basel); 2024 Jan; 16(1):. PubMed ID: 38251254
[TBL] [Abstract][Full Text] [Related]
5. Development and characterization of phage display-derived anti-toxin antibodies neutralizing TcdA and TcdB of
Raeisi H; Azimirad M; Asadzadeh Aghdaei H; Zarnani AH; Abdolalizadeh J; Yadegar A; Zali MR
Microbiol Spectr; 2023 Sep; 11(5):e0531022. PubMed ID: 37668373
[TBL] [Abstract][Full Text] [Related]
6. Isofagomine Inhibits Multiple TcdB Variants and Protects Mice from
Paparella AS; Brew I; Hong HA; Ferriera W; Cutting S; Lamiable-Oulaidi F; Popadynec M; Tyler PC; Schramm VL
ACS Infect Dis; 2024 Mar; 10(3):928-937. PubMed ID: 38334357
[No Abstract] [Full Text] [Related]
7. Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A.
Ho JG; Greco A; Rupnik M; Ng KK
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18373-8. PubMed ID: 16344467
[TBL] [Abstract][Full Text] [Related]
8.
Xiao X; Sarma S; Menegatti S; Crook N; Magness ST; Hall CK
ACS Chem Biol; 2022 Jan; 17(1):118-128. PubMed ID: 34965093
[No Abstract] [Full Text] [Related]
9. Structure of the full-length Clostridium difficile toxin B.
Chen P; Lam KH; Liu Z; Mindlin FA; Chen B; Gutierrez CB; Huang L; Zhang Y; Hamza T; Feng H; Matsui T; Bowen ME; Perry K; Jin R
Nat Struct Mol Biol; 2019 Aug; 26(8):712-719. PubMed ID: 31308519
[TBL] [Abstract][Full Text] [Related]
10. Isofagomine inhibits multiple TcdB variants and protects mice from
Paparella AS; Brew I; Hong HA; Ferriera W; Cutting S; Lamiable-Oulaidi F; Popadynec M; Tyler PC; Schramm VL
bioRxiv; 2023 Sep; ():. PubMed ID: 37781587
[No Abstract] [Full Text] [Related]
11. Crystal structure of Clostridium difficile toxin A.
Chumbler NM; Rutherford SA; Zhang Z; Farrow MA; Lisher JP; Farquhar E; Giedroc DP; Spiller BW; Melnyk RA; Lacy DB
Nat Microbiol; 2016 Jan; 1():15002. PubMed ID: 27571750
[TBL] [Abstract][Full Text] [Related]
12. Conformational analysis of Clostridium difficile toxin B and its implications for substrate recognition.
Swett R; Cisneros GA; Feig AL
PLoS One; 2012; 7(7):e41518. PubMed ID: 22844485
[TBL] [Abstract][Full Text] [Related]
13. Novel Dietary Proteins Selectively Affect Intestinal Health In Vitro after
Jochems PGM; Garssen J; Rietveld PCS; Govers C; Tomassen MMM; Wichers HJ; van Bergenhenegouwen J; Masereeuw R
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32932980
[TBL] [Abstract][Full Text] [Related]
14. Protease-stable DARPins as promising oral therapeutics.
Simeon RA; Zeng Y; Chonira V; Aguirre AM; Lasagna M; Baloh M; Sorg JA; Tommos C; Chen Z
Protein Eng Des Sel; 2021 Feb; 34():. PubMed ID: 34882774
[TBL] [Abstract][Full Text] [Related]
15. Innate Immune Defenses Mediated by Two ILC Subsets Are Critical for Protection against Acute Clostridium difficile Infection.
Abt MC; Lewis BB; Caballero S; Xiong H; Carter RA; Sušac B; Ling L; Leiner I; Pamer EG
Cell Host Microbe; 2015 Jul; 18(1):27-37. PubMed ID: 26159718
[TBL] [Abstract][Full Text] [Related]
16. Defined Nutrient Diets Alter Susceptibility to Clostridium difficile Associated Disease in a Murine Model.
Moore JH; Pinheiro CC; Zaenker EI; Bolick DT; Kolling GL; van Opstal E; Noronha FJ; De Medeiros PH; Rodriguez RS; Lima AA; Guerrant RL; Warren CA
PLoS One; 2015; 10(7):e0131829. PubMed ID: 26181795
[TBL] [Abstract][Full Text] [Related]
17. Novel riboswitch-binding flavin analog that protects mice against Clostridium difficile infection without inhibiting cecal flora.
Blount KF; Megyola C; Plummer M; Osterman D; O'Connell T; Aristoff P; Quinn C; Chrusciel RA; Poel TJ; Schostarez HJ; Stewart CA; Walker DP; Wuts PG; Breaker RR
Antimicrob Agents Chemother; 2015 Sep; 59(9):5736-46. PubMed ID: 26169403
[TBL] [Abstract][Full Text] [Related]
18. Fecal Microbiota Transplantation Eliminates Clostridium difficile in a Murine Model of Relapsing Disease.
Seekatz AM; Theriot CM; Molloy CT; Wozniak KL; Bergin IL; Young VB
Infect Immun; 2015 Oct; 83(10):3838-46. PubMed ID: 26169276
[TBL] [Abstract][Full Text] [Related]
19. A cfr-like gene from Clostridium difficile confers multiple antibiotic resistance by the same mechanism as the cfr gene.
Hansen LH; Vester B
Antimicrob Agents Chemother; 2015 Sep; 59(9):5841-3. PubMed ID: 26149991
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of Digital Enzyme-Linked Immunosorbent Assays for Ultrasensitive Detection and Quantification of Clostridium difficile Toxins in Stool.
Song L; Zhao M; Duffy DC; Hansen J; Shields K; Wungjiranirun M; Chen X; Xu H; Leffler DA; Sambol SP; Gerding DN; Kelly CP; Pollock NR
J Clin Microbiol; 2015 Oct; 53(10):3204-12. PubMed ID: 26202120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
